MATTIA BROSE APRN
Prescription History 1104365071
Nurse Practitioner - Family in Bloomfield, CT
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MATTIA BROSE APRN, an active Family specialist practicing in Bloomfield, CT. Our medical registry currently tracks 5 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 63 documented patient claims. Among these therapy options, the most frequently utilized medication is Lorazepam, which accounts for 14 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other CT PrescribersVs. CT Avg |
|---|---|---|---|
| Lorazepam | 14 | $18.08 | ▼ Less than typical |
About Lorazepam: This medication is used to treat anxiety. Show more ▾ Lorazepam belongs to a class of drugs known as benzodiazepines which act on the brain and nerves (central nervous system) to produce a calming effect. This drug works by enhancing the effects of a certain natural chemical in the body (GABA). A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent. In 2024, this provider wrote 14 Medicare prescriptions for Lorazepam, about a third of the volume of the typical Connecticut prescriber of this medication (48.1). Medicare paid an average of $18.08 per fill, versus $7.53 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 14 30-Day Fills standardized to 30-day supplies 359 Days of Medication total across all patients in 2024 | |||
| Trazodone Hcl | 14 | $8.74▼ below CT avg | ▼ Less than typical |
About Trazodone Hcl: This medication is used to treat depression. Show more ▾ Trazodone works by helping to restore the balance of a certain natural substance (serotonin) in the brain. A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309) In 2024, this provider wrote 14 Medicare prescriptions for Trazodone Hcl, about 17% of the volume of the typical Connecticut prescriber of this medication (82.8). Medicare paid an average of $8.74 per fill, versus $9.79 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CT average for this medication. 14 30-Day Fills standardized to 30-day supplies 236 Days of Medication total across all patients in 2024 | |||
| Clonazepam | 12 | $14.00 | ▼ Less than typical |
About Clonazepam: Clonazepam is used to prevent and control seizures. Show more ▾ This medication is known as an anticonvulsant or antiepileptic drug. It is also used to treat panic attacks. Clonazepam works by calming your brain and nerves. It belongs to a class of drugs called benzodiazepines. An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses. In 2024, this provider wrote 12 Medicare prescriptions for Clonazepam, about a quarter of the volume of the typical Connecticut prescriber of this medication (51.7). Medicare paid an average of $14.00 per fill, versus $9.70 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 335 Days of Medication total across all patients in 2024 | |||
| Tramadol Hcl | 12 | $8.92 | ▼ Less than typical |
About Tramadol Hcl: See also Warning section. Show more ▾ This medication is used to help relieve moderate to moderately severe pain. Tramadol belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. A narcotic analgesic proposed for severe pain. It may be habituating. In 2024, this provider wrote 12 Medicare prescriptions for Tramadol Hcl, about a quarter of the volume of the typical Connecticut prescriber of this medication (45.4). Medicare paid an average of $8.92 per fill, versus $8.59 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 187 Days of Medication total across all patients in 2024 | |||
| Pregabalin | 11 | $22.50▼ below CT avg | ▼ Less than typical |
About Pregabalin: This medication is used to treat pain caused by nerve damage due to diabetes, shingles (herpes zoster) infection, or spinal cord injury. Show more ▾ This medication is also used to treat pain in people with fibromyalgia. It is also used with other medications to treat certain types of seizures (focal seizures). A gamma-aminobutyric acid (GABA) derivative that functions as a CALCIUM CHANNEL BLOCKER and is used as an ANTICONVULSANT as well as an ANTI-ANXIETY AGENT. It is also used as an ANALGESIC in the treatment of NEUROPATHIC PAIN and FIBROMYALGIA. In 2024, this provider wrote 11 Medicare prescriptions for Pregabalin, about a third of the volume of the typical Connecticut prescriber of this medication (36.8). Medicare paid an average of $22.50 per fill, versus $28.16 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CT average for this medication. 11 30-Day Fills standardized to 30-day supplies 285 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for MATTIA BROSE APRN is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Family prescribing approach at this Bloomfield, CT practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among CT prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
